These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9153298)

  • 1. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
    Di Cola G; Cool MH; Accili D
    J Clin Invest; 1997 May; 99(10):2538-44. PubMed ID: 9153298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
    Johansson GS; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
    Chisalita SI; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
    Rizk NN; Saed GM; Diamond MP
    Fertil Steril; 2006 Oct; 86(4 Suppl):1217-22. PubMed ID: 16962112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I/insulin hybrid receptors in human endothelial cells.
    Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.
    Federici M; Zucaro L; Porzio O; Massoud R; Borboni P; Lauro D; Sesti G
    J Clin Invest; 1996 Dec; 98(12):2887-93. PubMed ID: 8981937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor type-1 receptor down-regulation associated with dwarfism in Holstein calves.
    Blum JW; Elsasser TH; Greger DL; Wittenberg S; de Vries F; Distl O
    Domest Anim Endocrinol; 2007 Oct; 33(3):245-68. PubMed ID: 16829014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes.
    Bäck K; Arnqvist HJ
    Growth Horm IGF Res; 2009 Apr; 19(2):101-11. PubMed ID: 18693051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
    Chisalita SI; Nitert MD; Arnqvist HJ
    Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I.
    Escrivá F; González-Rodriguez A; Fernández-Millán E; Rondinone CM; Alvarez C; Valverde AM
    J Cell Physiol; 2010 Oct; 225(1):214-22. PubMed ID: 20506299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma.
    Chagnon MJ; Elchebly M; Uetani N; Dombrowski L; Cheng A; Mooney RA; Marette A; Tremblay ML
    Can J Physiol Pharmacol; 2006 Jul; 84(7):755-63. PubMed ID: 16998539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice.
    Masternak MM; Al-Regaiey KA; Del Rosario Lim MM; Jimenez-Ortega V; Panici JA; Bonkowski MS; Bartke A
    Exp Gerontol; 2005; 40(8-9):679-84. PubMed ID: 16054319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.